Cardio Diagnostics Holdings revenue was $34.89k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $4.5k, down 31.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CDIO annual revenue was $34.9k, with 104.5% growth year-over-year.
CDIO past revenue growth
How has CDIO's revenue growth performed historically?
Cardio Diagnostics Holdings (NASDAQ: CDIO) reported Q4 2024 revenue of $4.51 thousand up 15.03% year over year. In the same quarter last year, Cardio Diagnostics Holdings's revenue was $5.31 thousand.
What was Cardio Diagnostics Holdings's revenue in 2024?
Cardio Diagnostics Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $34.89 thousand, a 104.45% increase year over year.
How much does Cardio Diagnostics Holdings make in a day?
Based on Cardio Diagnostics Holdings annual revenue for the past four years, CDIO makes an average of $36.85 per day.
What was Cardio Diagnostics Holdings's annual revenue growth in the past year?
As of Q2 2025, Cardio Diagnostics Holdings's revenue has grown 104.45% year over year. This is 393.24 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Cardio Diagnostics Holdings's revenue in the past year totaled $34.89 thousand.
How much does Cardio Diagnostics Holdings make in a year?
Cardio Diagnostics Holdings's revenue by year for the past four years is:
Cardio Diagnostics Holdings's revenue for the twelve months ending Dec 31, 2024 was $34.89 thousand, a 104.45% increase year over year.
Cardio Diagnostics Holdings's annual revenue for Dec 31, 2023 was $17.07 thousand, a 1,696.32% increase from 2022.
Cardio Diagnostics Holdings's annual revenue for 2022 was $950.00, a 5.44% increase from 2021.
Cardio Diagnostics Holdings's annual revenue for 2021 was $901.00, a Infinity% increase from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.